Breast Cancer Clinical Trial

Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer

Summary

The purpose of this research study is to evaluate how well the Stereo Navigator Biopsy Accessory for the PEM Flex solo II PET Scanner works for performing breast biopsy on suspicious lesions. This study will also allow the doctors to describe the features of PEM detected lesions and the results obtained using the PEM guided biopsy and will compare the time it took to complete a pre-operative work up using PEM versus MRI in patients with a suspicious breast lesion resulting in cancer.

View Full Description

Full Description

See brief summary.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

female
subject is 25-100 years of age
subjects has at least one breast imaging finding on mammography and/or ultrasound which is assessed as highly suggestive of malignancy and recommended to biopsy
subject is able to provide informed consent

Exclusion Criteria:

subject is pregnant
subject is actively lactating or discontinued breastfeeding less than 2 months ago
subject has breast implants
subject is scheduled for sentinel node procedure using radioactive Tc-99m within 24 hours of the PEM study
subject has contraindications for core biopsy and other invasive procedures
subject has Type I diabetes mellitus or poorly controlled Type II diabetes mellitus
subject has had surgery or radiation therapy on the study breast or has had chemotherapy within the past 12 months
subject has not fasted for 4-6 hours prior to the procedure and/or have a fasting blood glucose level greater than 140 mg/dl on day of PEM imaging

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT00981812

Recruitment Status:

Completed

Sponsor:

University of Cincinnati

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UC Hospital, The Barrett Center
Cincinnnati Ohio, 45219, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT00981812

Recruitment Status:

Completed

Sponsor:


University of Cincinnati

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider